BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30089595)

  • 21. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
    Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
    Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].
    Kang L; Zheng J; Zhu X
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effective mutation of epidermal growth factor receptor in synchronous multiple primary lung cancers: study of clinical, radiographic and pathological factors].
    Wang YJ; Feng H; Ma SR; Wang YC; Liu YY; Bai HJ; Zhao L
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2297-2301. PubMed ID: 31434406
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relationship between EGFR, ALK Gene Mutation and Imaging 
and Pathological Features in Invasive Lung Adenocarcinoma].
    Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.
    Kim YI; Paeng JC; Park YS; Cheon GJ; Lee DS; Chung JK; Kang KW
    AJR Am J Roentgenol; 2018 Jun; 210(6):1346-1351. PubMed ID: 29547059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma.
    Yano M; Sasaki H; Kobayashi Y; Yukiue H; Haneda H; Suzuki E; Endo K; Kawano O; Hara M; Fujii Y
    J Thorac Oncol; 2006 Jun; 1(5):413-6. PubMed ID: 17409892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
    Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
    AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
    Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
    Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
    Chen Y; Yang Y; Ma L; Zhu H; Feng T; Jiang S; Wei Y; Wang T; Sun X
    Eur J Radiol; 2019 Mar; 112():44-51. PubMed ID: 30777218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma.
    Sugano M; Shimizu K; Nakano T; Kakegawa S; Miyamae Y; Kaira K; Araki T; Kamiyoshihara M; Kawashima O; Takeyoshi I
    Oncol Rep; 2011 Nov; 26(5):1205-11. PubMed ID: 21811765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
    Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
    Mei D; Luo Y; Wang Y; Gong J
    Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
    Cai Y; Chen T; Zhang S; Tan M; Wang J
    J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.